By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevi Therapeutics 

New Haven  Connecticut    U.S.A.
Phone: 203-304-2499 Fax: 203-304-2434



Company News
Gil Yosipovitch, M.D. Joins Trevi Therapeutics’ Clinical Advisory Board 10/1/2014 10:17:10 AM
Trevi Therapeutics Selected To Exhibit Poster At 2014 Annual Meeting of the American College of Clinical Pharmacology 9/9/2014 11:35:50 AM
Trevi Therapeutics Announces The Issuance Of Two Patents Covering The Oral Sustained Release Formulation Of Nalbuphine ER 8/14/2014 8:05:09 AM
Trevi Therapeutics Announces Initiation Of A Pivotal Study Of Nalbuphine ER In Uremic Pruritus 7/14/2014 7:09:52 AM
Clinical Stage Biotech Trevi Therapeutics Brings In $25 Million Series B Financing 6/4/2014 6:40:51 AM
Trevi Therapeuitcs Exhibits Poster At 2014 Annual Meeting Of The Society For Investigative Dermatology 5/9/2014 7:49:57 AM
Trevi Therapeuitcs Presents Data at the 7th World Congress on Itch 9/25/2013 6:37:47 AM
Trevi Therapeuitcs Commences Clinical Study of Nalbuphine ER 5/6/2013 10:18:46 AM
Trevi Therapeuitcs Raises $10 Million Series A 12/18/2012 7:45:51 AM